SNDL Inc. SNDL
Medicinal Chemicals and Botanical Products · IPO 2019 · data as of November 13, 2026
SNDL Inc. (SNDL) is a healthcare company listed in the US with a market value of about $333M. In the twelve months to September 30, 2026 it had revenue of $646M and net income of -$41M, a net margin of -6.4%.
Its overall Stock Analiz score is 1.6 out of 5 (weak). The strongest part is financial health (3/5); the weakest is value (1/5).
Key numbers: a price to free cash flow of 11.5, 5-year revenue growth of 71% a year, a 5-year average ROIC of -9%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 66% below the current price.
About SNDL
SNDL is listed in the US and classified in medicinal chemicals and botanical products, IPO year 2019. Revenue went from $49M in 2019 to $691M in 2025, growth of about 55.5% a year. It was profitable in 0 of the last 8 years in our data.
Score: 1.6 / 5
Checks passed
- P/FCF below 20
- Profit margin improving
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Positive free cash flow
- Liabilities below 60% of assets
- 20% to 100% of free cash flow returned to shareholders
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
Valuation
Growth and quality
Financials, last 8 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $646M | $691M | $640M | $686M | $526M | $44M | $48M | $49M | — |
| Net income | -$41M | -$12M | -$66M | -$130M | -$248M | -$179M | -$183M | -$209M | -$10M |
| Free cash flow | $29M | $42M | $32M | -$18M | -$13M | -$126M | -$48M | -$172M | -$10M |
| EPS (diluted) | $-0.16 | $-0.05 | $-0.27 | $-0.54 | $-1.02 | $-0.73 | $-0.75 | $-0.86 | $-0.04 |
| Net margin | -6.4% | -1.7% | -10.3% | -19.0% | -47.0% | -404.4% | -382.9% | -427.1% | — |
| ROIC | — | -0.5% | -7.2% | -10.6% | -21.0% | -8.0% | -53.9% | -10.5% | -49.1% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is SNDL stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 66% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does SNDL pay a dividend?
Not currently.
Is SNDL a good stock to buy?
We do not give buy or sell advice. SNDL scores 1.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.